Advertisement

Topics

Search Results for "Brian Groves Pfizer Bio"

17:17 EST 20th February 2017 | BioPortfolio

Matching Channels

CTLA4 Mab rDNA Pfizer

Insulin rDNA inhaled Pfizer

Lymphocyte Immune Globulin Pfizer

Somatropin Hgh rDNA Pfizer

What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Ab Initio Announces Strategic Collaboration with Pfizer to Discover GPCR Activating Antibodies

Research collaboration and investment will fund Ab Initio’s platform expansion Announces Scientific Advisory Board appointments of Brian Kobilka, M.D., Timothy A. Springer, Ph.D., Robert Booth, ...

Reports: Bristol-Myers Squibb could be takeover target

Brian BerkRoche, Novartis, Pfizer and Gilead were all named as potential suitors. read more

FDA removes boxed label warning from Pfizer’s Chantix

Brian BerkRemoval based on the outcomes of EAGLES, the largest smoking cessation clinical trial in patients without and with a history of psychiatric disorder. read more

FDA approves removal of boxed label warning from Pfizer’s Chantix

Brian BerkRemoval based on the outcomes of EAGLES, the largest smoking cessation clinical trial in patients without and with a history of psychiatric disorder. read more

Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG ...

Pfizer Inc.Media:Steven Danehy, +1 978-273-3946Steven.Danehy@pfizer.comorInvestor:Chuck Triano, +1 212-733-3901Charles.E.Triano@pfizer.com Read more...

Pfizer Decides to Remain One Company

Pfizer announced its decision to remain one company after debating the possibility of splitting Pfizer Innovative Health and Pfizer Essential Health into two, separate publicly traded companies. ...

Pfizer will not split

Pfizer has announced that, after an extensive evaluation, the company’s board of directors and executive leadership team have determined the company is best positioned to maximize future shareholder...

Pfizer Receives Positive CHMP Opinion in Europe for XELJANZ® (tofacitinib citrate) for the ...

Pfizer U.S. Media:Steven Danehy, 978-273-3946Steven.Danehy@pfizer.comorPfizer Europe Media:Lisa O'Neill, +44 7929 339 560Lisa.O'Neill@pfizer.comorInvestors:Chuck Triano, 212-733-3901Char...

Matching PubMed Articles

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement